New pill may help cervical cancer patients keep weight and strength during chemo
NCT ID NCT07338487
First seen Jan 27, 2026 · Last updated May 14, 2026 · Updated 17 times
Summary
This study tests a new, easier-to-absorb form of megestrol acetate (a drug that boosts appetite) in 88 women with advanced cervical cancer who are undergoing chemoradiotherapy. The goal is to see if it helps prevent weight loss and muscle wasting, which are common and dangerous side effects of treatment. Participants will either receive the drug plus standard therapy or standard therapy alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xiangya Second Hospital of Central South University
RECRUITINGChangsha, Hunan, 410011, China
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.